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Background: Postoperative infections have been a major issue in
lung cancer surgery. We changed our perioperative prophylactic
antibiotic policy to a single dose of cefazolin before and after
surgery in July 2002.
Objective: To identify the risk factors of postoperative pneumonia
and empyema in lung cancer patients undergoing surgical resection.
Methods: From July 1992 through September 2003, 2105 patients
underwent primary lung cancer resection at our division. We re-
viewed 1855 eligible patients for possible risk factors of pneumonia
and empyema.
Results: Postoperative respiratory infections developed in 69 (3.7%)
patients. There were 58 (3.1%) pneumonia cases and 18 (1.0%)
cases of empyema. The mortality rate was 0.8% (15 patients). Nine
(0.5%) patients died from postoperative respiratory infections. Mul-
tivariate analysis showed age 75 years or older, forced expiratory
volume in 1 second as a percentage of forced vital capacity
(FEV1%) less than 70%, advanced pathologic stage, and induction
therapy to be independent risk factors of pneumonia. For postoper-
ative empyema, advanced age was the significant factor. Twelve of
18 patients (67%) with empyema were complicated with broncho-
pleural fistula. The infection incidence rate did not change signifi-
cantly after we modified our prophylactic antibiotic policy to a
single dose of cefazolin before and after surgery.
Conclusions: Lung cancer patients with advanced age, low FEV1%,
advanced pathologic stage, or induction therapy had a risk for
pneumonia after lung cancer surgery. Postoperative empyema was
associated with advanced age.
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Postoperative respiratory infection is a major issue in lungcancer surgery. Sok et al.1 reported that 34 of 194 patients
(18%) suffered from respiratory infections. The rates of
pneumonia after pulmonary resection have been reported to
range from 5.3%2 to 22%.3 Empyema is an intractable com-
plication and can lead to a long hospital stay. Duque et al.2
reported that 27 of 605 patients (4.4%) developed postoper-
ative empyema after lung cancer surgery, and Belda et al.4
reported an empyema rate of 6%.
Previous studies have shown smoking,3,5,6 comorbid
chronic obstructive pulmonary disease,6,7 advanced age,8 di-
abetes mellitus (DM),9 and obesity6 to be associated with
postoperative infections. The aim of this study was to identify
the risk factors of postoperative pneumonia and empyema
and to ascertain the efficacy of a single dose of prophylactic
antibiotics prophylaxis. We retrospectively reviewed patients
who underwent surgical resection for lung cancer and iden-
tified risk factors by univariate and multivariate analyses. To
our knowledge, there have been no reports evaluating the risk
factors associated with postoperative respiratory infections
after lung cancer surgery on a large scale by multivariate
analysis.
PATIENTS AND METHODS
From July 1992 through September 2003, 2105 con-
secutive patients underwent surgical resection for primary
lung cancer at the Division of Thoracic Surgery, National
Cancer Center Hospital East, Chiba, Japan. Retrospective
data collection from their medical records and analyses were
approved, and the need for informed consent from each
patient was waived by the institutional review board in
January 2005. Patients who underwent complete lung cancer
resection and had complete perioperative data were enrolled,
and 1855 were eligible. Their ages ranged from 22 to 90, with
an average of 64 years. There were 1191 men and 664
women.
The surgical procedures were lobectomy in 1625 cases
(87.6%), pneumonectomy in 100 (5.4%), wedge resection in
77 (4.2%), segmentectomy in 51 (2.7%), and bronchial re-
section in two (0.1%). We classified resection less than
lobectomy as limited resection, and we classified combined
resections with the chest wall, pericardium, great vessels, left
atrium, vertebral bodies, or diaphragm as extended resection.
Cancers were pathologically staged according to the
TNM classification system of the International Union Against
Cancer staging system.10 The pathological stages were as
follows: 724 (39.0%) were IA, 376 (20.3%) IB, 72 (3.9%)
IIA, 218 (11.8%) IIB, 266 (14.3%) IIIA, 167 (9.0%) IIIB, 28
(1.5%) IV, and four patients (0.2%) were stage 0. Of 31
patients who underwent induction therapy, 22 patients re-
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ceived chemotherapy, eight received chemoradiotherapy, and
one received radiotherapy.
We performed resection under general anesthesia with
an epidural catheter for postoperative pain control. All pa-
tients received local skin disinfection with povidone iodine
immediately before surgery. The thoracic cavity was lavaged
with 3 liters of warm saline immediately before chest closure.
The ribs, muscles, and subcutaneous tissue were closed using
absorbable sutures. Skin incisions were closed with buried
sutures and suture strips.
Patients received uniform pain control. Epidural anal-
gesia was continued for the first few days. Oral nonsteroidal
antiinflammatory drugs were also administered for pain con-
trol, starting on the first postoperative morning. There was no
attempt to assess levels of pain control.
All patients received perioperative prophylactic antibi-
otics. Until June 2002, the antibiotic regimen was at the
discretion of each attending surgeon, mostly the first-gener-
ation cephalosporin for a few days starting immediately
before surgery. From July 2002, patients received a single
dose of 1.0 g of cefazolin immediately before skin incision
and the same dose at 3 hours after surgery. If signs of
postoperative infection, such as fever, purulent sputum, or
infiltrative changes on a chest roentgenogram developed,
additional antibiotics were allowed.
We documented postoperative pneumonia and empy-
ema as postoperative respiratory infections. Postoperative
pneumonia was defined as purulent sputum and pulmonary
infiltrative changes on postoperative chest roentgenogram or
computed tomography. Empyema was defined as purulent
effusion in the postoperative thoracic cavity. These postop-
erative infections were not always be accompanied by a
fever, leukocytosis, and/or elevated serum C-reactive protein
level. Bronchoscopically proven bronchial stump failure with
persistent air leakage was defined as bronchopleural fistula.
We investigated the incidence of postoperative pneu-
monia and empyema and analyzed the association between
infection development and the following factors: age (75 or
75 yr), sex, smoking history (positive or negative), body
mass index 25 or 25), DM (positive or negative), forced
expiratory volume in 1 second as a percentage of forced vital
capacity (FEV1%; 70 or 70%), surgical procedure (lim-
ited resection, lobectomy, or extended resection), induction
therapy (positive or negative), and pathologic stage (I/II or
III/IV). Operative mortality was defined as a death from any
cause during the postoperative hospital stay.
Statistical Analysis
In univariate and multivariate analyses, the logistic
regression model was used to evaluate the risk factors asso-
ciated with postoperative infections. The data were calculated
using a StatView version 5 software package (SAS Institute
Inc, Cary, NC). A p value of less than 0.05 was defined as
indicative of statistical significance.
RESULTS
Postoperative respiratory infections developed in 69
(3.7%) of the 1855 patients. There were 58 (3.1%) pneumo-
nia cases and 18 (1.0%) empyema cases. Seven (0.4%)
patients developed both pneumonia and empyema. Eighteen
of the 1855 patients (1.0%) developed bronchopleural fistula
(BPF). Two of the 18 BPF patients underwent pneumonec-
tomy. In the 18 empyema patients, 12 were complicated with
BPF, and five were complicated with alveolar leakage or
pneumonia. The mortality rate was 0.8% (15 patients). There
were nine (0.5%) postoperative deaths from respiratory in-
fections, and all of these patients were male smokers who had
undergone a lobectomy. Of the 31 induction patients, seven
(23%) underwent pneumonectomy, and 16 (52%) underwent
extended resection. These rates were significantly higher
(p  0.001) than noninduction patients, indicating that induc-
tion patients had more advanced disease.
Table 1 shows the relationships between postoperative
infections and risk factors. More than 5% of the patients 75
years or older with FEV1% less than 70%, extended resec-
tion, induction therapy, or pathologic stage III/IV developed
TABLE 1. Postoperative Infections and Risk Factors
Variable n
Pneumonia
(n  58)
Empyema
(n  18)
Age (yr)
75 247 16 (6.5) 6 (2.4)
75 1608 42 (2.6) 12 (0.8)
Sex
Male 1191 48 (4.0) 16 (1.3)
Female 664 10 (1.5) 2 (0.3)
Smoking history
() 1259 50 (4.0) 15 (1.2)
() 596 8 (1.3) 3 (0.5)
BMI
25 1468 45 (3.1) 12 (0.8)
25 374 13 (3.5) 6 (1.6)
DM
() 142 2 (1.4) 0 (0)
() 1713 56 (3.3) 18 (1.1)
FEV1%
70% 499 28 (5.6) 6 (1.2)
70% 1356 30 (2.2) 12 (0.9)
Limited resection
() 128 2 (1.6) 0 (0)
() 1727 56 (3.2) 18 (1.0)
Lobectomy
() 1640 48 (2.9) 17 (1.0)
() 215 10 (4.7) 1 (0.5)
Extended resection
() 87 8 (9.2) 1 (1.2)
() 1768 50 (2.8) 17 (1.0)
Induction therapy
() 31 4 (12.9) 0 (0)
() 1825 54 (3.0) 18 (1.0)
Pathologic stage
I/II 1398 33 (2.4) 11 (0.8)
III/IV 457 25 (5.5) 7 (1.5)
BMI, body mass index; DM, diabetes mellitus; FEV1%, forced expiratory volume
as a percentage of forced vital capacity. Numbers in parentheses are percentages.
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postoperative pneumonia. In univariate analyses, advanced
age, male gender, smoking history, low FEV1%, surgical
procedure induction therapy, and pathologic stage were the
risk factors (Table 2). In multivariate analyses, advanced age,
low FEV1%, induction therapy, and pathologic stage were
shown to be independent risk factors (Table 3).
For postoperative empyema, patients 75 years or older
were at the highest risk (Table 1). In univariate analyses,
advanced age and male gender were the risk factors (Table 4).
Multivariate analysis showed that advanced age was a sig-
nificant risk factor for empyema (Table 5).
To investigate the relationships between perioperative
prophylactic antibiotics therapy and postoperative infections,
we compared the incidence of postoperative respiratory in-
fections between the two phases before and after July 2002,
when we changed our prophylactic antibiotics therapy at our
hospital (Table 6). After we changed our perioperative pro-
phylactic antibiotic policy, 76 of 321 patients (23.7%) re-
quired additional antibiotics. Fifty (3.3%) of 1534 patients
developed pneumonia before July 2002, and eight (2.5%) of
321 patients developed pneumonia after July 2002. For em-
pyema, there were 16 (1.0%) of 1534 and two (0.6%) of 262
patients before and after July 2002, respectively. Although
there were no statistically significant differences between the
two phases, the infection incidence rates reduced after we
changed the perioperative antibiotic policy to a single dose of
cefazolin before and after surgery.
DISCUSSION
In patients undergoing surgery for lung cancer, postop-
erative pneumonia and empyema strongly correlate with
outcome and constitute a major issue in patient management.
Nagasaki et al.11 showed a mortality associated with postop-
erative pneumonia of 25%, and mortality associated with
postoperative empyema was 22%. Because of hypoventila-
tion, secretory retention, pain, and inefficient cough, lung
cancer patients are at a high risk of developing atelectasis and
pneumonia after surgery.
We found that age 75 years or older was an independent
significant risk factor for postoperative pneumonia and em-
pyema. Iwamoto et al.8 investigated postoperative pneumonia
and revealed that elderly patients older than 65 years who
underwent thoracic surgery showed the highest incidence of
pneumonia. Smoking, obesity, and DM have been reported to
TABLE 2. Univariate Analysis of Relationships between Risk
Factors and Postoperative Pneumonia
Variable Risk Ratio 95% CI p
Age (yr) 0.0017
75 2.58 1.43–4.67
75 1.00
Sex 0.004
Male 2.75 1.38–5.47
Female 1.00
Smoking history 0.0038
() 3.04 1.43–6.45
() 1.00
Body mass index 0.69
25 1.14 0.61–2.13
25 1.00
DM 0.24
() 0.42 0.10–1.75
() 1.00
FEV1% 0.0003
70% 2.63 1.55–4.45
70% 1.00
Surgery
Extended 6.38 1.32–30.8 0.021
Lobectomy 3.36 1.54–7.34 0.0024
Limited 1.00
Induction therapy 0.0043
() 4.86 1.64–14.4
() 1.00
Pathologic stage 0.0013
III/IV 2.39 1.41–4.07
I/II 1.00
DM, diabetes mellitus; CI, confidence interval; FEV1%, forced expiratory volume
as a percentage of forced vital capacity.
TABLE 3. Multivariate Analysis of Relationships between
Risk Factors and Postoperative Pneumonia
Variable Risk Ratio 95% CI p
Age (yr) 0.0008
75 2.91 1.56–5.44
75 1.00
Sex 0.19
Male 1.85 0.74–4.65
Female 1.00
Smoking history 0.43
() 1.51 0.55–4.18
() 1.00
Body mass index 0.20
25 1.53 0.80–2.94
25 1.00
DM 0.14
() 0.34 0.08–1.43
() 1.00
FEV1% 0.026
70% 1.89 1.08–3.30
70% 1.00
Surgery
Extended 3.40 0.63–18.2 0.15
Lobectomy 1.94 0.79–4.74 0.15
Limited 1.00
Induction therapy 0.038
() 3.70 1.08–12.7
() 1.00
Pathologic stage 0.0052
III/IV 2.23 1.27–3.92
I/II 1.00
DM, diabetes mellitus; CI, confidence interval; FEV1%, forced expiratory volume
as a percentage of forced vital capacity.
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be definite risk factors of postoperative complications.3,5–9
However, we could not find a significant correlation between
postoperative pneumonia or empyema and these factors in
multivariate analysis.
Patients with chronic obstructive pulmonary disease
were shown to be at a high risk of postoperative pneumo-
nia.6,7 However, Cerfolio et al.12 concluded that pulmonary
complications were not associated with low FEV1. In the
present report, multivariate analysis revealed a preoperative
FEV1% of less than 70% was a significant risk factor for
postoperative pneumonia. When low FEV1 patients were 75
years or older, the risk of pneumonia was extremely high, at
10.7% (11/103; p 0.0001). For these patients with impaired
respiratory pulmonary function, preoperative rehabilitation
might be needed to reduce the risk of postoperative respira-
tory complications.13
Busch et al.3 showed that extended resection involving
either the chest wall or other adjacent structures was associ-
ated with pulmonary complications. They also reported a
significant increase in major pulmonary complications in
patients who had received induction chemotherapy. Martin et
al.14 reported that, among patients who received induction
therapy, the incidence of pneumonia and empyema were 12.1
and 1.3%, respectively. Although our multivariate analysis
did not show a correlation between the extent of surgical
resection and postoperative pneumonia, patients who under-
went induction therapy and those with advanced pathologic
stage were shown to have a significant risk of postoperative
pneumonia. The incidence of pneumonia after induction ther-
apy was similar to the results of Martin et al.,14 at 13%.
Induction therapy may be refrained in elderly patients.
Deschamps et al.15 studied empyema after pneumonec-
tomy and indicated that the risk of empyema was associated
with lower preoperative FEV1, lower diffusion capacity of
TABLE 4. Univariate Analysis of Relationships between Risk
Factors and Postoperative Empyema
Variable Risk Ratio 95% CI p
Age (yr) 0.018
75 3.31 1.23–8.91
75 1.00
Sex 0.045
Male 4.51 1.03–19.7
Female 1.00
Smoking history 0.17
() 2.38 0.69–8.27
() 1.00
Body mass index 0.18
25 1.98 0.74–5.31
25 1.00
DM 0.98
() — —
() —
FEV1% 0.54
70% 1.36 0.51–3.65
70% 1.00
Surgery
Extended — — 0.98
Lobectomy 1.10 0.15–8.44 0.92
Limited 1.00
Induction therapy 0.98
() — —
() —
Pathologic stage 0.17
III/IV 1.96 0.76–5.09
I/II 1.00
DM, diabetes mellitus; CI, confidence interval; FEV1%, forced expiratory volume
as a percentage of forced vital capacity.
TABLE 5. Multivariate Analysis of Relationships between
Risk Factors and Postoperative Empyema
Variable Risk Ratio 95% CI p
Age (yr) 0.0076
75 4.06 1.45–11.4
75 1.00
Sex 0.06
Male 5.98 0.92–38.7
Female 1.00
Smoking history 0.70
() 0.70 0.15–3.64
() 1.00
Body mass index 0.09
25 2.40 0.87–6.62
25 1.00
DM 0.98
() — —
() —
FEV1% 0.94
70% 0.96 0.34–2.71
70% 1.00
Surgery
Extended — — 0.99
Lobectomy 1.18 0.14–9.56 0.88
Limited 1.00
Induction therapy 0.99
() — —
() —
Pathologic stage 0.12
III/IV 2.21 0.82–5.97
I/II 1.00
DM, diabetes mellitus; CI, confidence interval; FEV1%, forced expiratory volume
as a percentage of forced vital capacity.
TABLE 6. Rates of Postoperative Pneumonia and Empyema
Period Total
Pneumonia
p
Empyema
p(n  58) (n  18)
July 1992 to
June 2002
1534 50 (3.3%) 0.47 16 (1.0%) 0.75
July 2002 to
September
2003
321 8 (2.5%) 2 (0.6%)
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lung to carbon monoxide, lower preoperative serum hemo-
globin, right pneumonectomy, bronchial stump reinforce-
ment, completion pneumonectomy, delayed chest tube re-
moval, and the amount of blood transfusions. We identified
age 75 years or older as a risk factor for empyema. Twelve of
18 empyema patients developed BPF. Had it not been for
BPF, the majority of empyema cases might have been pre-
vented. Although the role of bronchial stump coverage with a
flap in preventing BPF remains controversial,16 Taghavi et
al.17 recently reported that bronchial stump coverage with a
pedicled pericardial flap was highly effective in postpneumo-
nectomy BPF prevention. In this study, no patients receiving
induction therapy developed empyema or bronchopleural
fistula. This might be attributable to the protective pedicled
flap we used for these high-risk patients. Further prospective
study is necessary to confirm the role of bronchial stump
coverage with a pedicled flap, but a randomized study would
be unfeasible because of the rarity of BPF.
The Centers for Disease Control and Prevention rec-
ommended antimicrobial prophylaxis only when needed.18
Ilves et al.19 showed that prophylactic antibiotics were effec-
tive in reducing wound infections, but the incidence of
pulmonary infections and empyema was not significantly
decreased. Prolonged prophylactic antibiotics were reported
not to be effective against postoperative pleuropulmonary
infections. Olak et al.20 revealed that six doses of cefazolin
did not confer clinically important benefit beyond that ob-
tained from a single dose as prophylaxis in elective general
thoracic surgery. Our experience confirms these suggestions.
A small dosage is also beneficial costwise.
In conclusion, we identified risk factors for postopera-
tive respiratory infections in lung cancer patients. Elderly
patients and patients after induction therapy need intensive
perioperative management. Preoperative rehabilitation may
be beneficial for those with impaired lung function.
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